References
- JangSYJangSWKoJCelastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor αCancer Lett20113001576520934245
- RíosJLEffects of triterpenes on the immune systemJ Ethnopharmacol2010128111420079412
- KimDYParkJWJeoungDRoJYCelastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma modelEur J Pharmacol20096121–39810519356734
- SettyARSigalLHHerbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effectsSemin Arthritis Rheum200534677378415942912
- KannaiyanRShanmugamMKSethiGMolecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancerCancer Lett2011303192021168266
- SalminenALehtonenMPaimelaTKaarnirantaKCelastrol: molecular targets of Thunder God VineBiochem Biophys Res Commun2010394343944220226165
- HuangYZhouDHangTPreparation, characterization, and assessment of the antiglioma effects of liposomal celastrolAnticancer Drugs201223551552422343423
- YangFDongXGAnZMRetrospect and prospect of studies on Tripterygium wilfordii Hook fChin J Integr Med2005112899616150194
- LiuZMaLZhouGBThe main anticancer bullets of the Chinese medicinal herb, thunder god vineMolecules20111665283529721701438
- DaiYDeSanoJTangWNatural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaBPLoS One2010512e1415321170316
- DasSChaudhuryARecent advances in lipid nanoparticle formulations with solid matrix for oral drug deliveryAAPS Pharm Sci Tech20111216276
- Gonzalez-MiraENikolićSCalpenaACEgeaMASoutoEBGarcíaMLImproved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogelsJ Pharm Sci2012101270772522012873
- SeverinoPAndreaniTMacedoASCurrent state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug deliveryJ Drug Deliv [serial on the internet]2012 Article ID 75891. Available from: http://www.hindawi.com/journals/jdd/2012/750891/Accessed July 30, 2012
- ZhouLChenYZhangZHeJDuMWuQPreparation of tripterine nanostructured lipid carriers and their absorption in rat intestinePharmazie201267430431022570936
- Des RieuxAFievezVMomtazMHelodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epitheliumJ Control Release2007118329430217292503
- BolhassaniAPotential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancerBiochim Biophys Acta20111816223224621840374
- DeshayesSMorrisMCDivitaGHeitzFCell-penetrating peptides: tools for intracellular delivery of therapeuticsCell Mol Life Sci200562161839184915968462
- DietzGPProtection by neuroglobin and cell-penetrating peptide-mediated delivery in vivo: a decade of research. Comment on Cai et al: TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in miceExp Neurol20112271224231Exp Neurol20112311110
- Said HassaneFSalehAFAbesRGaitMJLebleuBCell penetrating peptides: overview and applications to the delivery of oligonucleotidesCell Mol Life Sci201067571572619898741
- ZhangZLvHZhouJNovel solid lipid nanoparticles as carriers for oral administration of insulinPharmazie200964957457819827297
- KibriaGHatakeyamaHHarashimaHA new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand systemInt J Pharm20114121–210611421414394
- MadaniFLindbergSLangelUFutakiSGräslundAMechanisms of cellular uptake of cell-penetrating peptidesJ Biophys [serial on the internet]. 2011; Article ID 414729. Available from: http://www.hindawi.com/journals/jbp/2011/414729/Accessed July 30, 2012
- JärverPLangelUThe use of cell-penetrating peptides as a tool for gene regulationDrug Discov Today20049939540215081956
- VarmaMVPanchagnulaREnhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivoEur J Pharm Sci2005254–544545315890503
- LiuDLiuZWangLZhangCZhangNNanostructured lipid carriers as novel carrier for parenteral delivery of docetaxelColloids Surf B Biointerfaces201185226226921435845
- NehillaBJAllenPGDesaiTASurfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticlesACS Nano20082353854419206580
- ChenYWangJYuanLZhouLJiaXTanXInteraction of the main components from the traditional Chinese drug pair Chaihu-Shaoyao based on rat intestinal absorptionMolecules201116119600961022095024
- LaiJLuYYinZHuFWuWPharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticlesInt J Nanomedicine20105132320161984
- ZhuangCYLiNWangMPreparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInt J Pharm20103941–217918520471464
- TorchilinVPMultifunctional nanocarriersAdv Drug Deliv Rev200658141532155517092599
- Marquele-OliveiraFSantanaDCTaveiraSFDevelopment of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiationJ Pharm Biomed Anal201053484385120634015
- KlangVMatskoNZimmermannAMVojnikovicEValentaCEnhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsionsInt J Pharm20103931–215216020434531
- JiaLJZhangDRLiZYPreparation and characterization of silybin-loaded nanostructured lipid carriersDrug Deliv2010171111819941406
- SaravanakumarGMinKHMinDSHydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistributionJ Control Release2009140321021719560497
- HiroseHTakeuchiTOsakadaHTransient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cellsMol Ther201220598499322334015
- LiuYHuMAbsorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal modelDrug Metab Dispos200230437037711901089
- ZahidMLuXMiZRobbinsPDCationic and tissue-specific protein transduction domains identification, characterization, and therapeutic applicationAdv Genet201069839520807603
- ZieglerAThermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycansAdv Drug Deliv Rev2008604–558059718045730
- FogedCNielsenHMCell-penetrating peptides for drug delivery across membrane barriersExpert Opin Drug Deliv20085110511718095931
- O’DriscollCMGriffinBTBiopharmaceutical challenges associated with drugs with low aqueous solubility – the potential impact of lipid-based formulationsAdv Drug Deliv Rev200860661762418155800